Correlation Analysis
Eli Lilly & Co. vs Regeneron Pharmaceuticals Inc
LLY vs REGN
+0.471
Moderate positive
When one moves up, the other tends to follow.
Eli Lilly & Co.
↗LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap 828.2B · 50,000 employees
Regeneron Pharmaceuticals Inc
↗REGN
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Market cap 80.7B · 15,410 employees
Time Series
Relative Performance
Who Moves First
REGN leads LLY by 2 days
REGN tends to move before LLY.
After testing 13 timing shifts, the strongest relationship was +0.471 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.647
15 periods · Return correlation when both series rose
Both Falling
-0.057
5 periods · Return correlation when both series fell
Diverging
-0.491
15 periods · Return correlation when series moved apart
R-Squared
22.2%
Share of variance in one series explained by the other.
Trend Agreement
64.0%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.001
95% CI: [0.427, 0.513]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Eli Lilly & Co.
LLY
Market cap 828.2B · 50,000 employees
Stock · 1,254 raw → 1,254 prepared
Series B
Regeneron Pharmaceuticals Inc
REGN
Market cap 80.7B · 15,410 employees
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
17
Estimated crossover points between normalized spreads.
Slope
0.2692
Linear regression slope.
Intercept
580.4941
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
LLY
Eli Lilly & Co.
Highest
+0.939
Vertex Pharmaceuticals Inc
VRTX · 1,254 data points
Lowest
-0.889
United Parcel Service, Inc. Class B
UPS · 1,254 data points
REGN
Regeneron Pharmaceuticals Inc
Highest
+0.487
Exxon Mobil Corporation
XOM · 1,254 data points
Lowest
-0.331
Tesla, Inc. Common Stock
TSLA · 1,254 data points
Saved 5 hours ago · ID: stock-lly-vs-stock-regn-daily